General

EC Healthcare Announces FY2020/21 Annual Results

HONG KONG, Jun 30, 2021 – (ACN Newswire) – EC Healthcare (the “Company”, which alongside with its subsidiaries is understood as the “Community”, SEHK stock code: 2138), the largest non-clinical institution clinical personnel in Hong Kong, publicizes this day its annual results for the fiscal Twelve months ended 31 March 2021 (the “Year”).Industry Highlights — Launched deal of strategic shareholders in conjunction with Dr. Cheng Chi Kong, Goldman Sachs Asia, Champion REIT, etc. — Earnings from clinical services surged 54.0% to HK$960 million, with its contributions to entire revenue rose to 46.1%– Earnings in the Mainland China elevated by 52.5% to HK$135 million– 2nd-half of entire revenue jumped 61.0% versus first half of, 2d-half of profit after tax surged by 223.2% versus first half of– Earnings sooner than passion, taxes, depreciation, and amortization (“EBITDA”) amounted to HK$397 million, profit after tax used to be HK$226 million and general earnings per share were 18.8 HK cents– The board of administrators (the “Board”) proposed final cash dividend of 12.9 HK cents per share, which alongside with the intervening time dividend of 3 HK cents per share, will bring the general annual dividend to 15.9 HK cents per share, representing an annual dividend payout ratio of 84.6%– As at 31 March 2021, the Community’s beefy-time and odd Registered Practitioners all over Hong Kong, the Mainland China and Macau elevated to 139, with more than 500 community clinical doctors– As at 31 March 2021, the Community’s mixture floor field of clinics and provider centres elevated by 32% to 398,000 sq. ftDuring the Year, despite the COVID-19 pandemic brought unprecedented challenges to the worldwide economy, the Community once any other time demonstrated industry resilience and maintained a valid performance below adversity. Below the leadership of administration with valid execution capabilities, the Community promptly adopted acceptable measures and proactively spoke back to the market changes, whereas on the identical time grasping the pattern and funding opportunities to consolidate the Community’s strengths. The Community boosted sales in the Hong Kong native market and in Mainland China thru proactive client engagement and stepped-up e-commerce campaigns. At some level of the Year, the Community obtained diverse clinical establishments whereas striving to stimulate unpleasant-promoting among varied clinical disciplines and stand up a particular enclosed eco-system in train to lengthen the Community’s market share in healthcare clinical services market and consolidate its leading yelp in the change.Benefited from the Community’s clinical asset integration procedure and the inflexible place an scream to for clinical services in the market, the revenue from clinical services supplied by the Community soundless elevated vastly by 54.0% to HK$960 million Twelve months-on-Twelve months (“yoy”), despite the absence of clinical vacationers attributable to the lockdown, and the contributions of clinical services to the general revenue rose by 14.1 percentage factors to 46.1%, coupled with the revenue from the Mainland China elevated by 52.5% to HK$135 million, utilizing the general revenue to amplify 6.8% to HK$2.08 billion. In particular, the pronounce momentum in the 2d half of of the Year used to be valid, with 2d-half of revenue soared by 61.0% in contrast to the first half of of the Year and 2d-half of profit after tax surged by 223.2% versus the first half of of the Year. The Community’s profit after tax used to be HK$226 million and the general earnings per share were 18.8 HK cents. EBITDA, which serves as a more trusty indicator of the Community’s profitability by with the exception of passion, tax, depreciation-owned property, plant and equipment, amounted to HK$397 million. The Board proposed a final cash dividend of 12.9 HK cents per share, which alongside with the intervening time dividend of 3 HK cents pers share, will bring the general annual dividend to 15.9 HK cents per share, representing an annual dividend payout ratio of 84.6%.Stable Fund-raising Capabilities and Stellar M&A ExecutionTo expend the first-mover advantage in the market and speed up deployment in industry segments with potential and market enlargement in the Increased Bay House, the Community presented deal of strategic shareholders (For small print, please discuss over with the chart below), demonstrating the Community’s famed fund-raising capabilities. In April 2021, the Community presented Dr. Cheng Chi Kong, Govt Vice Chairman and Chief Govt Officer of Tranquil World Pattern Co., Ltd. (SEHK stock code: 17) as its strategic shareholders thru shares placement. It’s some distance anticipated to extra empower the Community to deploy the clinical proper property procedure. Leveraging Dr. Cheng’s associated strategic designate of excessive-quality funding properties, this could perhaps perhaps furthermore facilitate the Community’s trusty layout in its industry pattern all over Hong Kong and the Mainland China and deepen the unpleasant-sector cooperation in clinical services and residential industrial proper property sectors. At some level of the Year, the Community continued the acquisition of varied clinical establishments to supply glossy clinical services and broadening of services spectrum (For small print, please discuss over with the desk below). The Community also taking into consideration integrating the obtained companies in train to totally exploit the synergies with the glossy companies of the Community, thereby extra consolidating the Community’s change leadership as an built-in clinical and healthcare personnel.Snappy Organic Boost and Ragged Replication CapabilityThe Community adheres to creating its companies thru natural pronounce as well as mergers and acquisitions. At some level of the Year, the Community opened glossy clinics and provider centres to meet the rising place an scream to for clinical and healthcare provider. (For small print, please discuss over with the desk below) As at 31 March 2021, the Community’s mixture floor field of clinics and provider centres elevated by 32.2% to (398,000) sq. ft.. The Community had 139 beefy-time and odd Registered Practitioners all over Hong Kong, the Mainland China and Macau, representing a yoy amplify of 44.8%. The Community also had more than 500 community clinical doctors.Leveraging its atmosphere friendly corporatization capabilities and aesthetic working functionality in the ravishing clinical market and its confirmed famed functionality in consolidating the Hong Kong clinical market, the Community has been continuously investing in the imprint energy, quality provider and IT platform to empower the fragmented and inefficient provider assets, and extra promote integration in the healthcare market. The Community’s moderate time for a glossy centre opening is glorious 75 days, its annualized buyer retention rate exceeds 81% and the customer acquisition designate glorious accounts for five.3% of the revenue, which is methodology ahead the change. Also, the Community’s glossy store can spoil even in six months on moderate and discontinue EBITDA breakeven in 9 months on moderate. The instant gentle-asset industry model adopted by the Community for rising industry has modified into more former.Mr. Eddy Tang, Chairman, Govt Director and Chief Govt Officer of EC Healthcare talked about, “EC Healthcare is always dedicated to building up an enclosed healthcare eco-system, attracting and declaring every public and non-public traffic, and reaching unpleasant-promoting among varied industry objects to beef up the loyalty of glossy possibilities. The Community will continue to put money into and toughen its core competitiveness in relation to imprint, provider, IT and company culture, and actively explore strategic alliances with companions from varied sectors defending property, pharmaceutical, insurance, telecom and files abilities in train to expand the breadth and depth of our healthcare and wellness provider offerings. On the quite plenty of hand, the Community is rising its market share by figuring out potential acquisition targets or thru an natural enlargement in the Increased Bay House. The Community hope to initiating 30 to 50 glossy provider centres and discontinue revenue aim of HK$6 billion by 2025, with HK$100 million of which comes from the Mainland China.”About EC Healthcare EC Healthcare is Hong Kong’s largest non-clinical institution clinical provider supplier*, leveraging its core companies of preventive and precision medication, and dedicated to creating clinical man made intelligence by integrating its multi-disciplinary clinical services. The switch, which is supported by the Community’s excessive-discontinue branding and quality buyer services, is geared toward offering possibilities safe and effective healthcare and clinical services with professionalism.The Community largely engages in the provision of 1-discontinue clinical and well being care services in Increased China. The Community affords a beefy differ of services and products below its famed brands, in conjunction with these of its one-discontinue ravishing clinical solutions supplier DR REBORN which has ranked first in Hong Kong by sales for years, significant care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, Tranquil York Backbone and Physiotherapy Heart NYMG, well being administration centre re:HEALTH, a vaccine centre Hong Kong Expert Vaccine HKPV, a entire dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology remedy centre reVIVE, a day blueprint centre HKMED, a uniqueness health center SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, experts central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Scientific Laboratories and a talented hair care center HAIR FOREST.*In accordance with an unbiased analysis performed by Frost and Sullivan in relation to revenue in 2019 and 2020For extra knowledge, please contact: iPR Ogilvy Restricted Callis Lau / Lorraine Luk / Ada Bite Tel: (852) 2136 6952 / 2169 0467 / 3920 7650 Fax: (852) 3170 6606 Email: [email protected] Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Related Articles

Back to top button
%d bloggers like this: